OcuSciences Inc.

Metabolic imaging to detect and monitor retinal disease

OcuSciences Inc.'s OcuMet Beacon is a noninvasive and rapid diagnostic screening tool for retinal disease. The current ophthalmic standard of care, optical coherence tomography, evaluates structural change in retinal thickness or swelling after retinal damage has occurred, but OcuMet can provide a level of functional testing before damage occurs, which is especially important for latent diabetics or patients undiagnosed for retinal diseases.

OcuSciences Inc.

3744 Plaza Drive

More from Archive

More from Medtech Insight